Is Intercostal Tube Enough in Management of Empyema

Launched by ASSIUT UNIVERSITY · Jan 30, 2024

Keywords

ClinConnect Summary

This clinical trial is looking at whether using an intercostal tube is enough to treat empyema, which is a condition where pus builds up in the space between the lungs and the chest wall. The study will take place at Assuit University Hospital and aims to find out how effective this treatment is for patients diagnosed with empyema.

To be eligible for the trial, patients must be admitted to the hospital with a confirmed diagnosis of empyema. However, people who have empyema due to surgery, trauma, or certain infections like tuberculosis will not be included in this study. Participants can expect to receive care through this treatment and will help researchers learn more about the best ways to manage empyema in the future. This trial is currently not recruiting participants, so it will begin at a later date.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • patients admitted to Assuit university Hospital and diagnosed with empyema
• Exclusion Criteria:
• • Patient diagnosed with Post-operative empyema
• • Patient diagnosed with post traumatic empyema
• • Patient diagnosed with Bronchopleural fistula
• • Patient diagnosed with TB